Live Breaking News & Updates on Waypoint Residential
Stay updated with breaking news from Waypoint residential. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
More on that story in a moment. But we begin tonight with a decline in the biotech sector. The decline in that sector, its worst of the year, was fueled not by a failed drug trial but by president ial hopeful Hillary Clinton. The nasdaq biotech index fell about 4 1 2 after clinton said in a tweet that as president shed crack down on what she sees as price gouging in the pharmaceutical industry. She promised more details tomorrow. Now, those comments were in response to a report in the New York Times of a 5,000 price increase, virtually overnight, in a 62yearold specialty drug. Now, weve talked a lot about the high cost of breakthrough new drugs coming to market. But as meg tirrell reports, older drugs arent immune. Reporter for a Small Company its making big waves for the drug industry. Turing pharmaceuticals, a private ....
More on that story in a moment. But we begin tonight with a decline in the biotech sector. The decline in that sector, its worst of the year, was fueled not by a failed drug trial but by president ial hopeful Hillary Clinton. The nasdaq biotech index fell about 4 1 2 after clinton said in a tweet that as president shed crack down on what she sees as price gouging in the pharmaceutical industry. She promised more details tomorrow. Now, those comments were in response to a report in the New York Times of a 5,000 price increase, virtually overnight, in a 62yearold specialty drug. Now, weve talked a lot about the high cost of breakthrough new drugs coming to market. But as meg tirrell reports, older drugs arent immune. Reporter for a Small Company its making big waves for the drug industry. Turing pharmaceuticals, a private ....
More on that story in a moment. But we begin tonight with a decline in the biotech sector. The decline in that sector, its worst of the year, was fueled not by a failed drug trial but by president ial hopeful Hillary Clinton. The nasdaq biotech index fell about 4 1 2 after clinton said in a tweet that as president shed crack down on what she sees as price gouging in the pharmaceutical industry. She promised more details tomorrow. Now, those comments were in response to a report in the New York Times of a 5,000 price increase, virtually overnight, in a 62yearold specialty drug. Now, weve talked a lot about the high cost of breakthrough new drugs coming to market. But as meg tirrell reports, older drugs arent immune. Reporter for a Small Company its making big waves for the drug industry. Turing pharmaceuticals, a private ....